Skip to main content
Figure 5 | BMC Pulmonary Medicine

Figure 5

From: Treatment of acute exacerbation of idiopathic pulmonary fibrosis with direct hemoperfusion using a polymyxin B-immobilized fiber column improves survival

Figure 5

Survival curves according to the severity of IPF during the 12 months before AE-IPF. A) Patients with GAP stage I disease. B) Patients with GAP-stage II or III disease (log-rank test, p = 0.021). In patients with more severe disease (GAP-stage II or III), the 12-month survival rate was significantly higher in those who were treated with PMX-DHP than in those who were treated without PMX-DHP (57.1% vs. 0%).

Back to article page